Search Results - "Alrawashdh, Neda" :: K.UTB vyhledávací portál

by Alrawashdh, Neda, McBride, Ali, Oh, Mok, Alkhatib, Nimer, Lee, Christopher, Martin, Jennifer, MacDonald, Karen, Abraham, Ivo
Published in Journal of the advanced practitioner in oncology (01.11.2022)

Get full text

Journal Article

Loading…

Institutional chart review on same-day pegfilgrastim administration in small cell lung cancer (SCLC) patients receiving myelotoxic chemotherapy

by Choi, Briana, Alrawashdh, Neda, Vraney, Jamie, McBride, Ali, Abraham, Ivo
Published in Journal of clinical oncology (01.10.2021)

Get full text

Journal Article

Loading…

An institutional evaluation of the safety and efficacy of same-day administration of pegfilgrastim in patients receiving chemotherapy for lung cancer

by Vraney, Jamie, AlRawashdh, Neda, Choi, Briana, Abraham, Ivo, McBride, Ali
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Loading…

Cost-efficiency analysis of conversion from reference pegfilgrastim to its biosimilar (pegfilgrastim-jmdb) and expanded access to food and transportation support for Medicare/Medicaid patients within the CMS Oncology Care Model

by MacDonald, Karen, AlRawashdh, Neda, McBride, Ali, Abraham, Ivo
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Loading…

Cost evaluation of adjunctive osimertinib use in resected epidermal growth factor receptor-positive non-small cell lung cancer

by Choi, Briana, Alrawashdh, Neda, McBride, Ali, Abraham, Ivo
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Loading…

$Economic Evaluation of Ibrutinib Versus Acalabrutinib Versus Zanubrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma$

Economic Evaluation of Ibrutinib Versus Acalabrutinib Versus Zanubrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma

by Alrawashdh, Neda, McBride, Ali, Slack, Marion, Abraham, Ivo
Published in Blood (05.11.2020)

Get full text

Journal Article

Loading…

$Economic Evaluation of Daratumumab and Pomalidomide and Dexamethasone Versus Isatuximab and Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma$

Economic Evaluation of Daratumumab and Pomalidomide and Dexamethasone Versus Isatuximab and Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

by Alrawashdh, Neda, Almutairi, Abdulaali, McBride, Ali, Abraham, Ivo
Published in Blood (05.11.2020)

Get full text

Journal Article

Loading…

Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer

by MacDonald, Karen, Alrawashdh, Neda, McBride, Ali, Abraham, Ivo
Published in Future oncology (London, England) (01.11.2021)

Get full text

Journal Article

Loading…

Cost-Effectiveness and Economic Burden Analyses on all First-Line Treatments of Chronic Lymphocytic Leukemia

by Alrawashdh, Neda, McBride, Ali, Erstad, Brian, Sweasy, Joann, Persky, Daniel O., Abraham, Ivo
Published in Value in health (01.10.2022)

Get full text

Journal Article

Loading…

Expanded access to anticancer treatments from conversion to biosimilar pegfilgrastim-cbqv in US breast cancer patients

by McBride, Ali, Alrawashdh, Neda, MacDonald, Karen, Abraham, Ivo
Published in Future oncology (London, England) (01.01.2022)

Get full text

Journal Article

Loading…

Cost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqv

by MacDonald, Karen, McBride, Ali, Alrawashdh, Neda, Abraham, Ivo
Published in Journal of medical economics (01.12.2020)

Get full text

Journal Article

Loading…

$Economic Evaluation for the US of Ibrutinib Versus Acalabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma$

Economic Evaluation for the US of Ibrutinib Versus Acalabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma

by Alrawashdh, Neda, Alkhatib, Nimer, McBride, Ali, Persky, Daniel, Abraham, Ivo
Published in Blood (29.11.2018)

Get full text

Journal Article

Loading…

Same-day pegfilgrastim or pegfilgrastim-cbqv prophylaxis in miniCHOP chemotherapy based regimens for non-Hodgkin lymphoma

by Bartels, Trace, McBride, Ali, AlRawashdh, Neda, Moore, Logan, Persky, Daniel O, Abraham, Ivo
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Loading…

$Economic evaluation of six and 12 month (m) treatment with isatuximab and carfilzomib and dexamethasone (IKd) versus daratumumab and carfilzomib and dexamethasone (DKd) in patients with relapsed or refractory multiple myeloma (RRMM)$

Economic evaluation of six and 12 month (m) treatment with isatuximab and carfilzomib and dexamethasone (IKd) versus daratumumab and carfilzomib and dexamethasone (DKd) in patients with relapsed or refractory multiple myeloma (RRMM)

by AlRawashdh, Neda, Choi, Briana, Obeng-Kusi, Mavis, Calamia, Matthias, McBride, Ali, Abraham, Ivo
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Loading…

Evaluation of same day pegfilgrastim (PFG) or PFG-cbqv prophylaxis of chemotherapy induced (Febrile) neutropenia (CIN/FN) in bendamustine plus rituximab (BR) and CHOP+/-R regimens in patients with lymphoma and chronic lymphocytic leukemia (CLL): Real-world, single-center experience

by McBride, Ali, AlRawashdh, Neda, Bartels, Trace, Moore, Logan, Persky, Daniel O, Abraham, Ivo
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Loading…

Survival trends in chronic lymphocytic leukemia in the era of oral targeted therapies in the United States: SEER database analyses (1985 to 2017)

by Alrawashdh, Neda, McBride, Ali, Persky, Daniel O., Sweasy, Joann, Erstad, Brian, Abraham, Ivo
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database